Bristol-Myers Squibb Company (BMY) Guggenheim’s Inaugural Healthcare Innovation Conference
Bristol-Myers Squibb Company (NYSE: BMY) FY 2024 Corporate Conference
Bristol-Myers Squibb Company (BMY) Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in Multiple Myeloma as Program Marks Ten Years
Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release
Bristol-Myers Squibb Company (BMY) Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial met its primary endpoint, demonstrating clinically meaningful and statistically significant reduction in Valsalva left ventricular outflow tract (LVOT) gradient at Week 28
Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release
Bristol-Myers Squibb Company (BMY) Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy (xanomeline and trospium chloride)
Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release
ADVERTISEMENT
Bristol-Myers Squibb Company (BMY) Three New Studies Show Viz.ai’s Cardio Suite Speeds Detection of Cardiac Disease and Improves Patient Follow-Up
Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release
Bristol-Myers Squibb Company (BMY) insitro and Bristol Myers Squibb Collaboration Expanded with Nomination of New Targets
Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release
Bristol-Myers Squibb Company (BMY) Bristol Myers Squibb Reinforces Leadership in oHCM with New Camzyos (mavacamten) Data at American College of Cardiology Annual Scientific Session & Expo 2026 (ACC.26)
Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release
Bristol-Myers Squibb Company (BMY) Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab)
Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release
ADVERTISEMENT
Bristol-Myers Squibb Company (BMY) Q1 2026 Earnings Call
Bristol-Myers Squibb Company (NYSE: BMY) Q1 2026 Earnings Conference
Bristol-Myers Squibb Company (BMY) Q1 2026 Earnings Announcement
Bristol-Myers Squibb Company (NYSE: BMY) Q1 2026 Earnings Announcement